? BIOSTATISTICS SHARED RESOURCE Shared Resource Leader: Madhu Mazumdar, PhD The Tisch Cancer Institute (TCI) Biostatistics Shared Resource Facility (BSRF) members participate actively in the design of new studies in basic science, clinical, epidemiological, survey, and cancer prevention. Early involvement of the BSRF members in the research teams enables the optimal design and analysis of pilot studies, adequate assessment of measurement properties of outcomes, assistance with appropriate database development, and meta-analysis of published literature, as needed for effective planning of new research. BSRF also fosters standardized review of protocols and monitoring of safety data. Members of the BSRF engage with faculty and staff in Information Technology to develop databases using Mount Sinai's electronic Research Application Portal (eRAP), perform analysis of small and `big' data (?omics? and high-dimensional data) in their collaboration with TCI investigators, and participate in graduate education programs developed for trainees and junior faculty in cancer research. In addition to providing training on analytic aspects of projects during collaborative consult sessions, BSRF members organize an Open House (for getting to know the biostatisticians in an informal setting), BioStat Clinic (sessions where consults are provided on a walk-in basis and often some training slides are presented on topics advertised a priori) and Journal Club (where methodology used in recent publications are discussed for potential application on local projects). All collaborative, review, and training work are provided free of charge with a strong requirement for biostatisticians to be included for significant FTE on all grants and contracts as a co-investigator. Biostatisticians are also required to be co-authors if ICJME criteria are met.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA196521-02
Application #
9149629
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Fujiwara, Naoto; Nakagawa, Hayato; Enooku, Kenichiro et al. (2018) CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut 67:1493-1504
Hogstad, Brandon; Berres, Marie-Luise; Chakraborty, Rikhia et al. (2018) RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med 215:319-336
Wu, Lisa M; Amidi, Ali; Tanenbaum, Molly L et al. (2018) Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study. Support Care Cancer 26:1917-1926
Chang, Sanders; Ru, Meng; Moshier, Erin L et al. (2018) The impact of radiation treatment planning technique on unplanned hospital admissions. Adv Radiat Oncol 3:647-654
Formenti, Silvia C; Rudqvist, Nils-Petter; Golden, Encouse et al. (2018) Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med 24:1845-1851
Likhterov, Ilya; Ru, Meng; Ganz, Cindy et al. (2018) Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes. Laryngoscope 128:2732-2739
Strub, Thomas; Ghiraldini, Flavia G; Carcamo, Saul et al. (2018) SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling. Nat Commun 9:3440
Sun, Zhen; Filipescu, Dan; Andrade, Joshua et al. (2018) Transcription-associated histone pruning demarcates macroH2A chromatin domains. Nat Struct Mol Biol 25:958-970
Kamath, Geetanjali R; Taioli, Emanuela; N Egorova, Natalia et al. (2018) Liver Cancer Disparities in New York City: A Neighborhood View of Risk and Harm Reduction Factors. Front Oncol 8:220
Buckstein, M; Rhome, R; Ru, M et al. (2018) Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes. Dis Esophagus 31:

Showing the most recent 10 out of 143 publications